Dr. Max C. Rudansky, MD

Dr. Rudansky practices at Glens Falls Hospital in Glens Falls, New York, part of Albany Med Health System.

Dr. Rudansky's NPI, 1649358938, was assigned on November 2, 2006. Dr. Rudansky graduated from Sidney Kimmel Medical College at Thomas Jefferson University in 1979. Dr. Rudansky holds New York license 152862.

Dr. Rudansky's primary practice is Glens Falls Hospital, at 100 Park Street, Glens Falls, NY 12801 in Warren County. The practice phone is (518) 926-1000.

Dr. Rudansky's primary practice is Glens Falls Hospital in Glens Falls, New York, part of Albany Med Health System. Dr. Rudansky is also affiliated with Albany Medical Center. The medical group on file is Glens Falls Hospital. Dmand AI also links Dr. Rudansky to 3 more medical groups and 2 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rudansky practices, 4 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Rudansky's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Rudansky is licensed in New York.

CMS data shows 440 Medicare services from Dr. Rudansky across 9 procedure codes in 2024, for 275 Medicare patients. Medicare paid $33,104 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 275 Medicare patients who saw Dr. Rudansky in 2024. The largest group is 75 to 84, with 119 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 23% are also on Medicaid. Their average risk score is 1.69, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Rudansky's median patient age at 72, with 50% women.

In 2024, Dr. Rudansky wrote 459 Medicare Part D claims for 128 patients. 82% of them were for generic drugs. CMS names the drug for 313 of them, across 8 drugs with 11 or more claims each, at $73,444 in total drug cost. In 2023, CMS named 176 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Rudansky for performance year 2024, reported through an alternative payment model (APM). Dr. Rudansky accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 77 general payments to Dr. Rudansky from 6 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 92% of the total. Abbvie Inc. paid the most, $44,214.

Dr. Rudansky graduated from Sidney Kimmel Medical College at Thomas Jefferson University in 1979.